STACI CLOUSE: Open Payments
NPI 1215234836 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 16 payments from 12 companies in 2025. Trend: 2023 $50 · 2024 $318 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Dexcom, Inc. | 3 | $51 |
| Insulet Corporation | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
Products named: Kerendia, Dexcom G6 Transmitter, Omnipod, ZENPEP, MINIMED 780G, GEMTESA, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across AR — which companies pay providers there.
